Clinical Trials Browser

NETWORK × Stomach Neoplasms × Ramucirumab × Clear all

NCT03766607 2019-09-19

Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer

Phase 2 Withdrawn

Gastrointestinal

Stomach Neoplasms